SCHEMBL1031222

SCHEMBL1031222

CN(C=O)c1ccc([O])cc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.39
CYP2A13 Q16696 1/20 0.39
ALDH1A1 P00352 4/20 0.35
TSHR P16473 3/20 0.35
HSD17B10 Q99714 2/20 0.35
ALOX15 P16050 1/20 0.35
ALDH3A1 P30838 1/20 0.32
ALDH1A3 P47895 1/20 0.32
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
TP53 P04637 1/20 0.30
MAPK1 P28482 1/20 0.30
HIF1A Q16665 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2091673 0.80 ALDH1A1 (0.52) CYP2A6CYP2A13ALDH1A1TSHRHSD17B10
SCHEMBL2099516 0.78 APP (0.48) CYP2A6CYP2A13ALDH1A1TSHRHSD17B10
SCHEMBL2090725 0.78 MAPT (0.40) CYP2A6CYP2A13ALDH1A1TSHRHSD17B10
SCHEMBL2096896 0.78 APP (0.48) CYP2A6CYP2A13MEN1KMT2ASMN1; SMN2
SCHEMBL203434 0.78 CYP2A6 (0.38) CYP2A6CYP2A13ALDH1A1TSHRHSD17B10
SCHEMBL2096460 0.78 ALDH1A1 (0.45) CYP2A6CYP2A13ALDH1A1TSHRHSD17B10
SCHEMBL1031223 0.78 APP (0.48) CYP2A6CYP2A13ALDH1A1HSD17B10ALOX15
SCHEMBL9512083 0.78 ALDH1A1 (0.54) CYP2A6CYP2A13ALDH1A1TSHRHSD17B10
SCHEMBL11098248 0.78 CYP2A6 (0.67) CYP2A6CYP2A13ALDH1A1HSD17B10ALDH3A1
SCHEMBL14093915 0.78 CYP2A6 (0.38) CYP2A6CYP2A13ALDH1A1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2357175-A1 isoquinoline derivatives AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN Fibrogen, Inc. (US) 2011-08-17 EP disclosed
EP-1644336-B1 NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN FIBROGEN INC (US) 2011-01-19 EP disclosed